Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
Feldman D, Cao D, Sartori S, Zhang Z, Hengstenberg C, Tron C, Anthopoulos P, Widder JD, Meneveau N, Stella PR, Ferrari M, Jeger R, Violini R, Dumonteil N, Chen S, Yan R, Nicolas J, Razuk V, Spirito A, Vogel B, Mehran R, Dangas G.
Feldman D, et al. Among authors: ferrari m.
Catheter Cardiovasc Interv. 2023 May;101(6):1134-1143. doi: 10.1002/ccd.30647. Epub 2023 Apr 10.
Catheter Cardiovasc Interv. 2023.
PMID: 37036268
Clinical Trial.